CERo Therapeutics Valuation
| CERO Stock | 0.06 0.01 19.00% |
CERo Therapeutics seems to be fairly valued based on Macroaxis valuation methodology. Our model approximates the value of CERo Therapeutics from reviewing the firm fundamentals such as shares outstanding of 51.35 M, and Return On Asset of -0.45 as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting CERo Therapeutics' valuation include:
Enterprise Value 12.7 M |
Fairly Valued
Today
Please note that CERo Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of CERo Therapeutics is based on 3 months time horizon. Increasing CERo Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CERo Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CERo Stock. However, CERo Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0567 | Real 0.0544 | Hype 0.0686 |
The intrinsic value of CERo Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CERo Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CERo Therapeutics Holdings, helps investors to forecast how CERo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CERo Therapeutics more accurately as focusing exclusively on CERo Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use CERo Therapeutics' intrinsic value based on its ongoing forecasts of CERo Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against CERo Therapeutics' closest peers.
CERo Therapeutics Cash |
|
CERo Valuation Trend
Knowing CERo Therapeutics' actual value is paramount for traders when making sound investment determinations. Using both CERo Therapeutics' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
CERo Therapeutics Total Value Analysis
CERo Therapeutics Holdings, is currently projected to have valuation of 12.73 M with market capitalization of 4.79 M, debt of 1.55 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CERo Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.73 M | 4.79 M | 1.55 M |
CERo Therapeutics Asset Utilization
One of the ways to look at asset utilization of CERo is to check how much profit was generated for every dollar of assets it reports. CERo Therapeutics Holdings, shows a negative utilization of assets of -0.45 percent, losing USD0.004528 for each dollar of assets held by the firm. Unproductive asset utilization signifies that the company is being less capable with each dollar of assets it shows. Put another way, asset utilization of CERo Therapeutics Holdings, shows how inefficient it operates for each dollar spent on its assets.CERo Therapeutics Ownership Allocation
CERo Therapeutics holds a total of 51.35 Million outstanding shares. CERo Therapeutics Holdings, shows 12.54 percent of its outstanding shares held by insiders and 9.04 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CERo Therapeutics Profitability Analysis
Net Loss for the year was (2.54 K) with profit before overhead, payroll, taxes, and interest of 0.About CERo Therapeutics Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of CERo Therapeutics Holdings,. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CERo Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing CERo Therapeutics's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of CERo Therapeutics's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of CERo Therapeutics. We calculate exposure to CERo Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CERo Therapeutics's related companies.CERo Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 6.5 M |
CERo Therapeutics Current Valuation Indicators
CERo Therapeutics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final CERo Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as CERo Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use CERo Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes CERo Therapeutics' worth.When determining whether CERo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CERo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cero Therapeutics Holdings, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cero Therapeutics Holdings, Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CERo Therapeutics. If investors know CERo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CERo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.19) | Return On Assets (0.45) |
The market value of CERo Therapeutics is measured differently than its book value, which is the value of CERo that is recorded on the company's balance sheet. Investors also form their own opinion of CERo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CERo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CERo Therapeutics' market value can be influenced by many factors that don't directly affect CERo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CERo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CERo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CERo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.